n n n ‘. concat(e. i18n. t(“search. voice. recognition_retry”),’n
The global home infusion treatments market revenue will reach $35. 69 billion by 2028.
Pune, India, Oct. 25, 2023 (GLOBE NEWSWIRE) — Home infusion treatment involves the intravenous or subcutaneous management of medications or biologics for an individual at home. The parts needed to make an infusion at home come with medications (antivirals, immunoglobulins), devices (a pump), and materials (tubes and catheters). The home infusion procedure requires coordination between multiple entities, adding patients, physicians, hospital discharge planners, fitness plans, home infusion pharmacies, and, where appropriate, home pharmacies. fitness agencies.
According to our most recent study on “Home Infusion Therapy Market Forecast to 2028 (COVID-19 Impact and Overall Analysis) through Product, Application, Route of Administration, and Geography”, the length of the home infusion therapy market was $21. 76 billion in 2022 and is expected to achieve $35. 69 billion through 2028; It is estimated to register a CAGR of 8. 6% from 2022 to 2028. The increasing occurrence of chronic disorders, coupled with the increasing geriatric population, reduced length of hospital stays, and increased burden of care, are driving the overall expansion of the home. Moreover, the growing healthcare prospects of emerging economies and the increasing prevalence of nosocomial infections are expected to provide lucrative opportunities for the home infusion treatments market during the forecast period.
Download a PDF brochure of patterns: https://www. theinsightpartners. com/pattern/TIPRE00004189
Global Home Infusion Therapy Market – Segmental Overview Based on product, the home infusion therapy market is segmented into infusion pumps, intravenous sets, intravenous cannulas, and needle-free connectors. In 2022, the infusion pumps segment accounted for the largest share of the market. Furthermore, the same segment is expected to register the highest CAGR in the forecast era as infusion pumps are widely used to feed and administer medicines to patients. The infusion pumps segment is sub-segmented into insulin pumps, elastomer pumps, and syringe pumps. In 2022, the insulin pump segment accounted for the largest share of the market. Based on applications, the home infusion treatments market is segmented into anti-infectives, endocrinology, enteral nutrition, specialty pharmaceuticals, hydration treatments, chemotherapy, and others. The anti-infectives segment held the highest market share in 2022. The endocrinology segment is expected to grow at the highest CAGR. Based on the direction of administration, the home infusion treatments market is divided into intramuscular, subcutaneous, and epidural. In 2022, the intramuscular segment held the largest share in the home infusion treatments market and is also expected to register the highest CAGR.
Global Home Infusion Therapy Market Analysis: Competitive Landscape and Key Developments B. Braun Melsungen AG, Micrel Medical Devices SA, Baxter International Inc, Nipro Corp, Becton Dickinson and Co, Fresenius Kabi AG, ICU Medical Inc, JMS Co Ltd, Eitan Medical Ltd, and Terumo Corp are the major home infusion corporations operating in the Home Infusion Treatment market. Market leaders in new product launches, expansion and diversification, as well as acquisition strategies, that allow them to access existing business opportunities.
In January 2023, Eitan Medical announced the opening of its new production facility at the company’s headquarters. On-site production will expand Eitan Medical’s production scale of its Pharmaceutical Solutions division. The facility will manufacture the Sorrel portable drug delivery platform in multiple device configurations, adding Sorrel portable injectors in vials and cartridges, prefilled and pre-filled in number one boxes up to 50 mL, as well as small-volume frame injectors.
In May 2022, Fresenius Kabi finalized the acquisition of Ivenix, a manufacturer of infusion systems. Fresenius Kabi now offers healthcare professionals in the U. S. the following options:The U. S. Department of Agriculture and Human Services has a broad and developing portfolio of complex infusion pumps and responses to meet desires throughout the care continuum.
In January 2022, ICU Medical Inc announced that it had completed the acquisition of Smiths Medical from Smiths Group plc. Smiths Medical’s business includes ambulatory syringes and infusion sets, vascular access and conduits for life-saving care. When combined with ICU Medical’s existing business, the combined corporations create a leading infusion treatment corporation with combined revenues estimated at approximately $2. 5 billion.
Request a copy of this report at https://www. theinsightpartners. com/buy/TIPRE00004189
In June 2021, Micrel Medical Devices announced the expansion of its footprint with the announcement of a new distribution partnership with Baxter in Australia and New Zealand for Rythmic PN, an ambulatory infusion pump for home parenteral nutrition.
In June 2021, Micrel Medical and Baxter Healthcare (Baxter) announced an agreement for the distribution of the Micrel Mini Rythmic PN infusion pump for parenteral nutrition (PN). Micrel Mini Rythmic PN is an ambulatory infusion pump that supports patients receiving parenteral nutrition in the hospital at home. Under the agreement, Baxter Healthcare will be the exclusive distributor of the Micrel Mini Rythmic PN infusion pump and accessories in New Zealand.
Explore others published through The Insight Partners:
Home and Alternative Site Infusion Therapy Market: Global Analysis and Prognosis to 2030
Home Health Care Market: Global Analysis and Forecast to 2028
About Us: Insight Partners is a full-service provider of industry studies with actionable insights. We, our clients, find answers to their study desires through our syndicated studios and consulting services. We specialize in industries such as Semiconductors & Electronics, Aerospace & Defense, Automotive & Transportation, Biotechnology, Healthcare IT, Manufacturing & Construction, Medical Devices, Technology, Media & Telecommunications, Chemicals & Materials.
Contact Us: If you have any questions related to this report or would like additional information, please contact us:
Contact Person: Ankit Mathur Email: sales@theinsightpartners. com Phone: 1-646-491-9876 Press Release: https://www. theinsightpartners. com/pr/home-infusion-therapy-market